Original Article

Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells

Correspondence to: Thierry Grand-Perret

Newly synthesized apolipoprotein E (apoE) is incompletely secreted and partially degraded by hepatocytes. To evaluate current models concerning apoE's role in remnant lipoprotein clearance by the liver, we performed a detailed and quantitative pulse-chase analysis of apoE secretion, subcellular distribution, and proteolytic degradation by the human hepatoma cell line HepG2. Only about 35% of newly synthesized apoE were found to be secreted to the culture medium. As determined by a protease-protection assay, a substantial amount of newly synthesized apoE was transported to the cell surface, constituting more than half of the cellular apoE under steady-state conditions. A subpopulation representing almost 40% of newly secreted apoE was rapidly rebound to the cell surface, indicating a dynamic equilibrium between cell surface and secreted apoE. These pools of newly synthesized apoE were subject to proteolytic turnover that occurred in lysosomes, presumably after re-endocytosis. We found that the proteolytic turnover of cell surface and secreted apoE was regulated by the availability of apoE ligands, being almost completely suppressed by the presence of lipoprotein-containing human serum or isolated lipoproteins, namely LDL and HDL. The characteristics of regulated degradation of cell surface apoE shed new light on potential physiological functions of this pool of apoE.

Our results provide evidence that hepatocytes are capable of forming a large pool of cell surface-associated apoE, thereby supporting the previously proposed secretion-recapture model for apoE.—Schmitt, M., and T. Grand-Perret. Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells. J. Lipid Res. 1999. 40: 39–49.

Supplementary key words: apolipoprotein E, secretion, cell surface, proteolysis, HepG2 cells, secretion-recapture model

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Kockx, W. Jessup, and L. Kritharides Regulation of Endogenous Apolipoprotein E Secretion by Macrophages Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1060 - 1067. [Abstract] [Full Text] [PDF]

				J. P. Davies, C. Scott, K. Oishi, A. Liapis, and Y. A. Ioannou Inactivation of NPC1L1 Causes Multiple Lipid Transport Defects and Protects against Diet-induced Hypercholesterolemia J. Biol. Chem., April 1, 2005; 280(13): 12710 - 12720. [Abstract] [Full Text] [PDF]

				S. I. Malloy, M. K. Altenburg, C. Knouff, L. Lanningham-Foster, J. S. Parks, and N. Maeda Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3 Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 91 - 97. [Abstract] [Full Text] [PDF]

				J. W. Burgess and Y. L. Marcel Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface J. Lipid Res., September 1, 2001; 42(9): 1413 - 1420. [Abstract] [Full Text] [PDF]

				C. Maugeais, U. J. F. Tietge, K. Tsukamoto, J. M. Glick, and D. J. Rader Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice J. Lipid Res., October 1, 2000; 41(10): 1673 - 1679. [Abstract] [Full Text]

				P. C. N. Rensen, M. C. Jong, L. C. van Vark, H. van der Boom, W. L. Hendriks, T. J. C. van Berkel, E. A. L. Biessen, and L. M. Havekes Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo. EVIDENCE FOR RETROENDOCYTOSIS J. Biol. Chem., March 17, 2000; 275(12): 8564 - 8571. [Abstract] [Full Text] [PDF]

				Y. Zhao and T. Mazzone Transport and Processing of Endogenously Synthesized ApoE on the Macrophage Cell Surface J. Biol. Chem., February 18, 2000; 275(7): 4759 - 4765. [Abstract] [Full Text] [PDF]